Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 1, 2010, Pages 149-154

  Xia, Ning ^a   Daiber, Andreas ^a   Habermeier, Alice ^a   Closs, Ellen I ^a   Thum, Thomas ^b   Spanier, Gerrit ^a   Lu, Qing ^a   Oelze, Matthias ^a   Torzewski, Michael ^a   Lackner, Karl J ^a   Münzel, Thomas ^a   Förstermann, Ulrich ^a   Li, Huige ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; APOLIPOPROTEIN E; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE 1; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; ISOENZYME; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; N(G) NITROARGININE METHYL ESTER; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RESVERATROL; SIRTINOL; SIRTUIN 1; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; 3-NITROTYROSINE; ANTIOXIDANT; BIOPTERIN; RNA; SAPROPTERIN; STILBENE DERIVATIVE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INACTIVATION; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; GENETICS; HEART MUSCLE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; BIOPTERIN; GTP CYCLOHYDROLASE; ISOENZYMES; MALE; MALONDIALDEHYDE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STILBENES; SUPEROXIDE DISMUTASE; SUPEROXIDES; TYROSINE;

EID: 77957220423     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.168724     Document Type: Article

References (40)

1. Alp NJ, McAteer MA, Khoo J, Choudhury RP, and Channon KM (2004) Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24:445-450.
2. Baur JA and Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506.
3. Bradamante S, Barenghi L, and Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22:169-188.
4. Brandes RP and Kreuzer J (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65:16-27.
5. Cao Z and Li Y (2004) Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 489:39-48.
6. Cooke JP (2004) Asymmetrical dimethylarginine: the Uber marker? Circulation 109:1813-1818.
7. Crabtree MJ, Tatham AL, Al-Wakeel Y, Warrick N, Hale AB, Cai S, Channon KM, and Alp NJ (2009) Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 284:1136-1144.
8. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, Zhang C, et al. (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297:H13-H20.
9. Del Rio D, Stewart AJ, and Pellegrini N (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 15:316-328.
10. Feron O, Dessy C, Moniotte S, Desager JP, and Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905.
11. Förstermann U (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5:338-349.
12. Förstermann U and Münzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708-1714. (Pubitemid 43754233)
13. Griendling KK (2004) Novel NAD(P)H oxidases in the cardiovascular system. Heart 90:491-493.
14. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, and Keynton RS (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells. J Biol Chem 280:7460-7468.
15. Klinge CM, Wickramasinghe NS, Ivanova MM, and Dougherty SM (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22:2185-2197.
16. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201-1209.
17. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG (2001) Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:1282-1288.
18. Li H and Förstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254. (Pubitemid 30141371)
19. Li H and Förstermann U (2009a) Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15:3133-3145.
20. Li H and Förstermann U (2009b) Resveratrol: a multifunctional compound improving endothelial function. Editorial to: "Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats" by S. Soylemez et al. Cardiovasc Drugs Ther 23:425-429.
21. Li H, Wallerath T, Münzel T, and Förstermann U (2002) Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7:149-164.
22. Li H, Witte K, August M, Brausch I, Gödtel-Armbrust U, Habermeier A, Closs EI, Oelze M, Münzel T, and Förstermann U (2006a) Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J Am Coll Cardiol 47:2536-2544.
23. Li Y, Cao Z, and Zhu H (2006b) Up-regulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 53:6-15.
24. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25:402-408.
25. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, and Irani K (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104:14855-14860. (Pubitemid 350003232)
26. Michan S and Sinclair D (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404:1-13.
27. Milne JC and Denu JM (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12:11-17.
28. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450:712-716.
29. Paravicini TM and Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31 (Suppl 2):S170-S180.
30. Schmidt TS and Alp NJ (2007) Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (London) 113:47-63.
31. Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U, and Li H (2009) Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60 (Suppl 4):111-116.
32. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K, and Horio Y (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285:8375-8382.
33. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD, Tsikas D, Ertl G, and Bauersachs J (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56:666-674.
34. Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, Podlutsky A, and Csiszar A (2007) Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292:H2417-H2424.
35. Viappiani S and Schulz R (2006) Detection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular disease. Am J Physiol Heart Circ Physiol 290:H2167-H2168.
36. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, and Förstermann U (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652-1658.
37. Wei CC, Wang ZQ, Tejero J, Yang YP, Hemann C, Hille R, and Stuehr DJ (2008) Catalytic reduction of a tetrahydrobiopterin radical within nitric-oxide synthase. J Biol Chem 283:11734-11742.
38. Wenzel P, Schulz E, Oelze M, Müller J, Schuhmacher S, Alhamdani MS, Debrezion J, Hortmann M, Reifenberg K, Fleming I, et al. (2008) AT1-receptor blockade by telmisartan up-regulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med 45:619-626.
39. Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hübschle T, Mang C, Strobel H, Suzuki T, Kleinert H, et al. (2008) Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther 325:370-379.
40. Xu H, Goettsch C, Xia N, Horke S, Morawietz H, Förstermann U, and Li H (2008) Differential roles of PKCα and PKCε in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med 44:1656-1667.